- トップ
- 研究業績
- Perl AE, Larson RA, Podoltsev NA, Strickland SA, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Récher C, Yoon SS, Hosono N, Onozawa M, Chiba S, Kim HJ, Hasabou N, Lu Q, Tiu R, Levis MJ. Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial. Blood (doi: 10.1182/blood.2021011583.) Online ahead of print Jan 26, 2022
Perl AE, Larson RA, Podoltsev NA, Strickland SA, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Récher C, Yoon SS, Hosono N, Onozawa M, Chiba S, Kim HJ, Hasabou N, Lu Q, Tiu R, Levis MJ. Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial. Blood (doi: 10.1182/blood.2021011583.) Online ahead of print Jan 26, 2022
2022/04/18
- 研究業績
- Perl AE, Larson RA, Podoltsev NA, Strickland SA, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Récher C, Yoon SS, Hosono N, Onozawa M, Chiba S, Kim HJ, Hasabou N, Lu Q, Tiu R, Levis MJ. Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial. Blood (doi: 10.1182/blood.2021011583.) Online ahead of print Jan 26, 2022
« Matsuoka R, Sakamoto N, Kato T, Chiba S, Noguchi M. A case of solitary ... | Ikezoe T, Noji H, Ueda Y, Kanda Y, Okamoto S, Usuki K, Matsuda T, Akiya... »
